Drug Interactions with Calcium Channel Blockers: Possible Involvement of Metabolite-Intermediate Complexation with CYP3A
- 1 February 2000
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 28 (2) , 125-130
- https://doi.org/10.1016/s0090-9556(24)15118-5
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- The interaction of diltiazem with lovastatin and pravastatinPublished by Wiley ,1998
- Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations*Clinical Pharmacology & Therapeutics, 1998
- Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone*Clinical Pharmacology & Therapeutics, 1998
- Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with RitonavirThe Journal of Clinical Pharmacology, 1998
- Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugsBiochemical Pharmacology, 1995
- Identification of P450 enzymes involved in metabolism of verapamil in humansNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1993
- [55] Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compoundsPublished by Elsevier ,1991
- Drug interactions with calcium antagonistsPharmacology & Therapeutics, 1990
- Xenobiotic and endobiotic inhibitors of cytochrome p-450dbl function, the target of the debrisoouine/sparteine type polymorphismBiochemical Pharmacology, 1988
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951